GR3024812T3 - Amylin activity assays - Google Patents

Amylin activity assays

Info

Publication number
GR3024812T3
GR3024812T3 GR970402446T GR970402446T GR3024812T3 GR 3024812 T3 GR3024812 T3 GR 3024812T3 GR 970402446 T GR970402446 T GR 970402446T GR 970402446 T GR970402446 T GR 970402446T GR 3024812 T3 GR3024812 T3 GR 3024812T3
Authority
GR
Greece
Prior art keywords
rise
amylin
lactate
simulate
activity assays
Prior art date
Application number
GR970402446T
Other languages
English (en)
Inventor
Andrew Young
Garth James Smith Cooper
Timothy J Rink
Original Assignee
Amylin Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/640,478 external-priority patent/US5234906A/en
Application filed by Amylin Pharmaceuticals Inc filed Critical Amylin Pharmaceuticals Inc
Publication of GR3024812T3 publication Critical patent/GR3024812T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
GR970402446T 1991-01-10 1997-09-22 Amylin activity assays GR3024812T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/640,478 US5234906A (en) 1991-01-10 1991-01-10 Hyperglycemic compositions
US66652791A 1991-03-08 1991-03-08
PCT/US1992/000185 WO1992011863A1 (en) 1991-01-10 1992-01-10 Amylin activity assays

Publications (1)

Publication Number Publication Date
GR3024812T3 true GR3024812T3 (en) 1998-01-30

Family

ID=27093565

Family Applications (1)

Application Number Title Priority Date Filing Date
GR970402446T GR3024812T3 (en) 1991-01-10 1997-09-22 Amylin activity assays

Country Status (10)

Country Link
US (1) US6048514A (el)
EP (1) EP0525149B1 (el)
JP (1) JP2818296B2 (el)
AT (1) ATE155689T1 (el)
CA (1) CA2077265A1 (el)
DE (1) DE69221040T2 (el)
DK (1) DK0525149T3 (el)
ES (1) ES2107528T3 (el)
GR (1) GR3024812T3 (el)
WO (1) WO1992011863A1 (el)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU222249B1 (hu) 1991-03-08 2003-05-28 Amylin Pharmaceuticals Inc. Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
ES2232811T3 (es) * 1992-05-15 2005-06-01 Amylin Pharmaceuticals, Inc. Pruebas sobre anticuerpos para la amilina.
WO1994018571A1 (en) * 1993-02-12 1994-08-18 Amylin Pharmaceuticals, Inc. Mcf-7 binding site assays
US6936584B1 (en) 1998-02-13 2005-08-30 Amylin Pharmaceuticals, Inc. Mixed amylin activity compounds
US20040038861A1 (en) * 2001-11-26 2004-02-26 Cooper Garth J. S. Methods and compositions for normalizing lipid levels in mammalian tissues
US20040142393A1 (en) * 2002-08-01 2004-07-22 Cooper Garth James Smith Methods of use of compounds with preptin function
US7339347B2 (en) * 2003-08-11 2008-03-04 Reserve Power Cell, Llc Apparatus and method for reliably supplying electrical energy to an electrical system
EP1719447A1 (de) * 2005-05-07 2006-11-08 F. Hoffmann-La Roche AG Verfahren und Vorrichtung zur Bestimmung der Glucose-Konzentration in Gewebflüssigkeit
CN101808615B (zh) * 2007-08-24 2013-05-15 巴斯夫欧洲公司 包含苯并三唑和部花青的混合物
JP6358942B2 (ja) * 2014-12-05 2018-07-18 沢井製薬株式会社 エンドトキシンの測定用試薬及びエンドトキシンの測定方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8316032D0 (en) * 1983-06-11 1983-07-13 Tanabe Seiyaku Co Benzothiazepine derivatives
US5280014A (en) * 1988-01-11 1994-01-18 Amylin Pharmaceuticals, Inc. Treatment of obesity and essential hypertension and related disorders
US5266561A (en) * 1988-01-11 1993-11-30 Amylin Pharmaceuticals, Inc. Treatment of type 2 diabetes mellitus
US5260275A (en) * 1990-08-14 1993-11-09 Amylin Pharmaceuticals, Inc. Hypoglycemics
US5321008A (en) * 1991-01-10 1994-06-14 Amylin Pharmaceuticals, Inc. Methods and compositions for treatment of diabetes mellitus, hypoglycemia, and other conditions
US5234906A (en) * 1991-01-10 1993-08-10 Amylin Pharmaceuticals, Inc. Hyperglycemic compositions
US5376638A (en) * 1992-09-01 1994-12-27 Amylin Pharmaceuticals, Inc. Methods for treating renin-related disorders with amylin antagonists

Also Published As

Publication number Publication date
ES2107528T3 (es) 1997-12-01
DK0525149T3 (da) 1997-12-01
JPH05505625A (ja) 1993-08-19
WO1992011863A1 (en) 1992-07-23
ATE155689T1 (de) 1997-08-15
US6048514A (en) 2000-04-11
EP0525149A1 (en) 1993-02-03
EP0525149B1 (en) 1997-07-23
DE69221040T2 (de) 1997-11-13
EP0525149A4 (en) 1993-08-25
JP2818296B2 (ja) 1998-10-30
DE69221040D1 (de) 1997-09-04
CA2077265A1 (en) 1992-07-11

Similar Documents

Publication Publication Date Title
TW369599B (en) A reagent strip and a method for measuring glucose concentration in a sample of whole blood
TWI256975B (en) Compositions containing a urea derivative dye for detecting an analyte and methods for using the same
DK0463524T3 (da) Sammensætning og fremgangsmåde til analysering for ketonstoffer
RU2002113055A (ru) Тестирующая полоска с реагентом для определения содержания анализируемого вещества
CA2075193A1 (en) Specimen test unit
DE3476455D1 (en) Polymer catalyst transducers and use thereof in test kits for analytical methods
GB2321967A (en) Opaque reaction matrix for the analysis of whole blood
AU6482201A (en) Slide-in cassette for a cup for testing of drugs of abuse
CA2235316A1 (en) A method for detecting antipolymer antibodies and a diagnostic test kit for use in aiding the diagnosis of silicone related diseases (srd)
GR3024812T3 (en) Amylin activity assays
EP0353985A3 (en) Nucleic acid probe for detection of neisseria gonorrhoea
AU591072B2 (en) Screening test for reverse-transcriptase containing virus
NO950426D0 (no) Analyse for bestemmelse av protein i en biologisk pröve
ATE107418T1 (de) Nachweis von analyt in partikel enthaltenden proben.
Kerry et al. Standardization of β-thromboglobulin (β-TG) and platelet factor 4 (PF4): a collaborative study to establish international standards for β-TG and PF4
DE69229954D1 (de) Nukleinsäurenachweis
BR0016287A (pt) Dispositivo para determinações analìticas
NO920624L (no) Reagens for paavisning av fibrinolytisk aktivitet
CN201083739Y (zh) 侧流层析测试装置
DK518189D0 (da) Antistofanalysereagens
KR890700397A (ko) 생물학적 반응강화용 소용적의 신속 혼합방법 및 장치
AU4532993A (en) Optical blood hemostatic analysis apparatus and method
HUT53229A (en) Process for radioimmunological determination of 3'-azido-3'-deoxythymidine content of biological samples
Harris et al. A single step polarographic assay of glycogen in muscle tissue and a note on the action of amyloglucosidase
BR9914294A (pt) Dispositivo de medição da atividade enzimática de amostra alimentar sólida, sua utilização e processo de medida da atividade enzimática de um alimento